| 
              
              
              Open Access  
 
              
              
              
              Research 
              
              
(Published 
				online: 
				03-02-2016)  
              2. 
				
				
				Hypoglycemic, hypolipidemic and 
				antioxidant effects of pioglitazone, insulin and synbiotic in 
				diabetic rats - 
				
				K. Kavitha, A. Gopala Reddy, K. Kondal Reddy, C. S. V. Satish 
				Kumar, G. Boobalan and K. Jayakanth 
              
              Veterinary World, 9(2): 118-122   
              
   
                
                
doi: 
              
				
				10.14202/vetworld.2016.118-122 
                
				  
				
				K. Kavitha: 
				
				Department of Veterinary Pharmacology and Toxicology, College of 
				Veterinary Science, Hyderabad - 500 030, Telangana, India; 
				kavithakalyan_23@yahoo.co.in 
				
				A. Gopala Reddy: 
				
				Department of Veterinary Pharmacology and Toxicology, College of 
				Veterinary Science, Hyderabad - 500 030, Telangana, India; 
				gopalareddy123@rediffmail.com 
				
				K. Kondal Reddy: 
				
				Department of Livestock Products Technology, College of 
				Veterinary Science, Hyderabad - 500 030, Telangana, India; 
				kkkredddy5@rediffmail.com 
				
				C. S. V. Satish Kumar: 
				
				Department of Veterinary Pharmacology and Toxicology, College of 
				Veterinary Science, Hyderabad - 500 030, Telangana, India; 
				satish513512@gmail.com 
				
				G. Boobalan: 
				
				Department of Veterinary Pharmacology and Toxicology, College of 
				Veterinary Science, Hyderabad - 500 030, Telangana, India; 
				bhupalvets@gmail.com 
				
				K. Jayakanth: 
				
				Department of Veterinary Pharmacology and Toxicology, College of 
				Veterinary Science, Hyderabad - 500 030, Telangana, India; 
				dr.koppakajayakanth@gmail.com   
				
				Received: 15-07-2015, Revised: 10-12-2015, Accepted: 19-12-2015, 
				Published online: 03-02-2016 
				  
				
              	
              	Corresponding author:K. Kavitha, e-mail: kavithakalyan_23@yahoo.co.in 
 
              Citation: 
				
				Kavitha K, Reddy AG, Reddy KK, Kumar CSVS, Boobalan G, Jayakanth 
				K (2016) Hypoglycemic, hypolipidemic and antioxidant effects of 
				pioglitazone, insulin and synbiotic in diabetic rats, 
				
				Veterinary World 9(2): 
				118-122. 
 
              
				Abstract 
 
				
				
				Aim: 
				
				The objective of the study was to assess the effect of 
				combination treatment of insulin,
				
				
				pioglitazone and synbiotic on streptozotocin (STZ)-induced 
				diabetic rats. 
				
				
				Materials and Methods: 
				
				Diabetes mellitus was induced chemically by intraperitoneal 
				administration of STZ (40 mg/kg b.wt) to male Sprague-Dawley 
				rats. The rats were divided randomly into six groups of six rats 
				in each. Group 1 was maintained as a normal control. Group 2 was 
				maintained as diabetic control; Group 3 was treated with 
				insulin; Group 4 with insulin + synbiotic; Group 5 with insulin 
				+ pioglitazone; and Group 6 with insulin + synbiotic + 
				pioglitazone. All the animals were treated for 60 days. 
				
				
				Results: 
				
				Body weights, and concentration of reduced glutathione (GSH), 
				and high-density lipoproteins cholesterol were significantly 
				(p<0.05) reduced, whereas the concentration of blood glucose, 
				total cholesterol, triglycerides, protein carbonyls and 
				thiobarbituric acid reacting substances, and the activity of GSH 
				peroxidase were significantly (p<0.05) elevated in Group 2 at 
				the end of 8th week as compared to Group 1. The treatment Groups 
				3, 4, 5 and 6 revealed improvement in all the parameters, and 
				the highest improvement was observed in combination Group 6. 
				
				
				Conclusion: 
				
				From this study, it is concluded that combination of insulin, 
				pioglitazone and synbiotic is useful in treating diabetes. 
				
				Keywords: 
				
				diabetes, insulin, oxidative stress, pioglitazone, synbiotic. 
 
              References 
 
				
					| 1. Wang, C., Guan, Y. and Yang, J. (2010) Cytokines in the 
					progression of pancreatic β-cell dysfunction. Int. J. 
					Endocrinol., 2010: 1-10. http://dx.doi.org/10.1155/2010/515136
 PMid:21113299 PMCid:PMC2989452
 |  
					|  |  
					| 2. Shanmugam, K.R., Mallikarjuna, K. and Reddy, K.S. (2011) 
					Effect of alcohol on blood glucose and antioxidant enzymes 
					in the liver and kidney of diabetic rats. Indian J. 
					Pharmacol., 43: 330-335. http://dx.doi.org/10.4103/0253-7613.81504
 PMid:21713042 PMCid:PMC3113389
 |  
					|  |  
					| 3. Biswas, A., Rabbani, S.I. and Devi, K. (2012) Influence 
					of experimental heart failure and hyperlipidemia in rats. 
					Indian J. Pharmacol., 44: 333-339. http://dx.doi.org/10.4103/0253-7613.96305
 PMid:22701242 PMCid:PMC3371455
 |  
					|  |  
					| 4. Pérez-Cobas, A.E., Moya, A., Gosalbes, M.J. and Latorre, 
					A. (2015) Colonization resistance of the gut microbiota 
					against Clostridium difficile. Antibiotics, 4: 337-357. http://dx.doi.org/10.3390/antibiotics4030337
 |  
					|  |  
					| 5. Canis, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., 
					Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, 
					A. and Lambert, D.M. (2009) Changes in gut microbiota 
					control inflammation in obese mice through a mechanism 
					involving GLP-2-driven improvement of gut permeability. Gut, 
					58: 1091-1103. http://dx.doi.org/10.1136/gut.2008.165886
 PMid:19240062 PMCid:PMC2702831
 |  
					|  |  
					| 6. Asemi, Z., Khorrami-Rad, A., Alizadeh, S.A., Shakeri, H. 
					and Esmaillzadeh, A. (2014) Effects of synbiotic food 
					consumption on metabolic status of diabetic patients: A 
					double-blind randomized cross-over controlled clinical 
					trial. Clin. Nutr., 33(2): 198-203. http://dx.doi.org/10.1016/j.clnu.2013.05.015
 PMid:23786900
 |  
					|  |  
					| 7. Patterson, J.W. and Lazarow, A. (1955) Determination of 
					glutathione. Methods Biochem. Anal., 2: 259-278. http://dx.doi.org/10.1002/9780470110188.ch9
 PMid:14393570
 |  
					|  |  
					| 8. Paglia, D.E. and Valentine, W.N. (1967) Studies on the 
					quantitative and qualitative characterization of erythrocyte 
					glutathione peroxidase. J. Lab. Clin. Med., 70: 158-159. PMid:6066618
 |  
					|  |  
					| 9. Balasubramanian, K.A., Manohar, M. and Mathan, V.I. 
					(1988) An unidentified inhibitor of lipid peroxidation in 
					intestinal mucosa. Biochem. Biophys., 962: 51-58. http://dx.doi.org/10.1016/0005-2760(88)90094-x
 |  
					|  |  
					| 10. Levine, R.L., Garland, D., Oliver, C.N., Amici, A., 
					Climent, I., Lenz, A.G., Ahn, B.W., Shaltiel, S. and 
					Stadtman, E.R. (1990) Determination of carbonyl content in 
					oxidatively modified proteins. Methods Enzymol., 186: 
					464-478. http://dx.doi.org/10.1016/0076-6879(90)86141-H
 |  
					|  |  
					| 11. Suthagar, E.S., Soudamani, S., Yuvaraj, S., Aruldhas, 
					M.M. and Balasubramanian, K. (2009) Effects of 
					streptozotocin-induced diabetes and insulin replacement on 
					rat ventral prostate. Biomed. Pharmacother., 63: 43-50. http://dx.doi.org/10.1016/j.biopha.2008.01.002
 PMid:18313883
 |  
					|  |  
					| 12. Derosa, G. and Maffioli, P. (2012) Peroxisome 
					proliferator activated receptor-γ (PPAR-γ) agonists on 
					glycemic control, lipid profile and cardiovascular risk. 
					Curr. Mol. Pharmacol., 5: 272-281. http://dx.doi.org/10.2174/1874467211205020272
 PMid:22122457
 |  
					|  |  
					| 13. Bogacka, I., Xie, H., Bray, G.A., and Smith, S.R. (2004) 
					The effect of pioglitazone on peroxisome 
					proliferator-activated receptor-γ target genes related to 
					lipid storage in vivo. Diabetes Care, 27: 1660-1667. http://dx.doi.org/10.2337/diacare.27.7.1660
 PMid:15220243
 |  
					|  |  
					| 14. Roselino, M.N., Pauly-Silveira, N.D., Cavallini, D.C., 
					Celiberto, L.S., Pinto, R.A., Vendramini, R.C. and Rossi, 
					E.A. (2012) A potential synbiotic product improves the lipid 
					profile of diabetic rats. Lipids Health Dis., 11: 114. http://dx.doi.org/10.1186/1476-511X-11-114
 PMid:22963080 PMCid:PMC3502481
 |  
					|  |  
					| 15. Devesh, C., Kritika, M., Anroop, N., Kumar, S.P. and 
					Sumeet, G. (2012) Spirulina reverses histomorphological 
					changes in diabetic osteoporosis in pioglitazone treated 
					rats. J. Diabetes Metab., S1-006: 2-7. http://dx.doi.org/10.4172/2155-6156.s1-006
 |  
					|  |  
					| 16. Ozasa, H., Ayaori, M., Iizuka, M., Terao, Y., UtoKondo, 
					H., Yakushiji, E. and Ikewaki, K. (2011) Pioglitazone 
					enhances cholesterol efflux from macrophages by increasing 
					ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: Findings 
					from in vitro and ex vivo studies. Atherosclerosis, 219: 
					141-150. http://dx.doi.org/10.1016/j.atherosclerosis.2011.07.113
 PMid:21862012
 |  
					|  |  
					| 17. Vitali, B., Ndagijimana, M., Maccaferri, S., Biagi, E., 
					Guerzoni, M.E. and Brigidi, P. (2012) An in vitro evaluation 
					of the effect of probiotics and prebiotics on the metabolic 
					profile of human microbiota. Anaerobe, 18: 386-391. http://dx.doi.org/10.1016/j.anaerobe.2012.04.014
 PMid:22579985
 |  
					|  |  
					| 18. Liong, M.T., Dunshea, F.R. and Shah, N.P. (2007) Effects 
					of a synbiotic containing Lactobacillus acidophilus ATCC 
					4962 on plasma lipid profiles and morphology of erythrocytes 
					in hypercholesterolaemic pigs on high- and low-fat diets. 
					Br. J. Nutr., 98: 736-744. http://dx.doi.org/10.1017/S0007114507747803
 PMid:17490507
 |  
					|  |  
					| 19. Hsiao, P.J., Hsieh, T.J., Kuo, K.K., Hung, W.W., Tsai, 
					K.B., Yang, C.H. and Shin, S.J. (2008) Pioglitazone 
					retrieves hepatic antioxidant DNA repair in a mice model of 
					high fat diet. BMC Mol. Biol., 9(1): 82. http://dx.doi.org/10.1186/1471-2199-9-82
 |  
					|  |  
					| 20. D'Souza, A., Fordjour, L., Ahmad, A., Cai, C., Kumar, D. 
					and Valencia, G. (2010) Effects of probiotics, prebiotics, 
					and synbiotics on messenger RNA expression of caveolin-1, 
					NOS, and genes regulating oxidative stress in the terminal 
					ileum of formula-fed neonatal rats. Pediatr. Res., 67: 
					526-531. http://dx.doi.org/10.1203/PDR.0b013e3181d4ff2b
 PMid:20101198
 |  
					|  |  
					| 21. Mandal, A., Patra, A., Mandal, S., Roy, S., Mahapatra, 
					S.D., Mahapatra, T.D., Paul, T., Das, K., Mondal, K.C. and 
					Nandi, D.K. (2015) Therapeutic potential of different 
					commercially available synbiotic on acetaminophen-induced 
					uremic rats. Clin. Exp. Nephrol., 19(2): 168-177. http://dx.doi.org/10.1007/s10157-014-0971-4
 PMid:24740592
 |  |